Mad Money Uncovered...
Health Care: Drugs
Amgen Inc (AMGN: NASDAQ)
$102.18 -3.45 | -3.27%
05/20/13 - 04:00 PM ET
Growth Rates
| GROWTH RATES |
|---|
| REVENUE (Trailing 12 Quarters) |
| EARNINGS PER SHARE (Trailing 12 Quarters) |
| DIVIDENDS (Trailing 12 Quarters) |
Portfolios with AMGN
- Portfolio NameUser Type
- ContributorTechnical Setups for the We...
- ContributorHigh Volume Technicals for ...
- UserDividend Stocks
- ContributorTechnical Setups for the We...
- ContributorTechnical Setups for the We...
- UserStevo
- ContributorPotential Dividend Hikes fo...
- UserMike Fatah's Mega Stock Por...
- UserGFNN Stockdiagnostics 23
- UserLong Term Stock Picks
Latest AMGN Headlines from TheStreet
- The Next Big Thing In Biotech: Large-Cap Earnings
04.18.13 | 09:04 am - Amgen Inc Stock Buy Recommendation Reiterated (AMGN) 04.15.13 | 10:04 am
- Today's Featured Drugs Gainer: Amgen Inc (AMGN) 04.12.13 | 05:04 pm
- 4 Stocks Driving The Drugs Industry Higher 04.12.13 | 01:04 pm
- Amgen Stock Hits New 52-Week High (AMGN) 04.10.13 | 12:04 pm
- 5 Health Care Stocks Ready to Break Out 04.09.13 | 11:04 am
- Biotech Multiples Are Soaring But M&A Is Dead 04.08.13 | 12:04 pm
- Amgen Inc (AMGN): Today's Favorite Drugs Gainer 04.04.13 | 05:04 pm
- 5 Stocks Dragging In The Health Care Sector 04.03.13 | 01:04 pm
- Amgen Inc Stock Buy Recommendation Reiterated (AMGN) 04.03.13 | 10:04 am
Press Releases for AMGN
- Amgen Announces Webcast Of 2013 First Quarter Financial Results - PR Newswire 04.18.13 | 04:04 pm
- Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles For Recoupment Policies Covering Major Compliance Failures - PR Newswire 04.04.13 | 08:04 am
- Amgen Announces Top-Line Results Of Phase 3 Talimogene Laherparepvec Trial In Melanoma - PR Newswire 03.19.13 | 06:03 pm
- Amgen Announces 2013 Second Quarter Dividend - PR Newswire 03.06.13 | 04:03 pm
- Amgen To Present At The Cowen And Company 33rd Annual Health Care Conference - PR Newswire 03.01.13 | 04:03 pm
- Amgen Statement On Government Budget Analysis For Oral-Only Treatments For Dialysis Patients - PR Newswire 02.22.13 | 05:02 pm
- Amgen Announces Call For Nominations For 2013 Breakaway From Cancer® Champions - PR Newswire 02.08.13 | 09:02 am
- Amgen To Webcast 2013 Business Review Meeting On February 7 - PR Newswire 01.31.13 | 04:01 pm
- Amgen Announces Results From Phase 3 PAVES Study Evaluating Neulasta® (pegfilgrastim) In Patients With Colorectal Cancer - PR Newswire 01.26.13 | 10:01 am
- Amgen Backs States' Efforts To Enact Biosimilar Legislation That Allows For Substitution And Supports Patient Safety - PR Newswire 01.25.13 | 07:01 pm
Partner Headlines for AMGN
- Big Cap Leaders Slide But Show Little Technical Damage - Investor's Business Daily 04.15.13 | 07:04 pm
- Pockets of Strength In Top Groups, Few Leaders Basing - Investor's Business Daily 04.15.13 | 06:04 pm
- Stocks End With Mild Losses; Nasdaq Rises 2.8% For Week - Investor's Business Daily 04.12.13 | 05:04 pm
- Can New Psoriasis Drugs Scratch Investors' Itch? - Investor's Business Daily 04.04.13 | 01:04 pm
- Cree, Seagate, Sandisk: Why Richie Freeman Likes Them - Investor's Business Daily 04.02.13 | 06:04 pm
- Biotech Breakout Boosting ETFs - Benzinga 03.28.13 | 03:03 pm
- Wall St rises as Fed reaffirms policies - Financial Times 03.20.13 | 08:03 pm
- Celgene Leads Handful Of Big Cap Stocks To New Highs - Investor's Business Daily 03.11.13 | 06:03 pm
- When To Add A New Full Position In A Good Stock - Investor's Business Daily 03.11.13 | 06:03 pm
- PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for March 01, 2013 - NASDAQ 02.27.13 | 02:02 pm
